COMP <GO>
NTLA vs QDEL // OPERATING MARGIN
Intellia Therapeutics Inc. (NASDAQ) VS. QuidelOrtho Corporation (NASDAQ) • 15-METRIC TALLY: NTLA 3
— QDEL 4
▲ OPERATING MARGIN LEADER: QDEL
LAST: $11.66 (-6.50%) • MKT CAP: $1.63B
operating-margins
-60.00%
LAST: $14.03 (+5.89%) • MKT CAP: $962.1M
operating-margins
-33.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NTLA VS. QDEL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NTLA | QDEL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -21.35% | -8.80% | -12.55 | QDEL | /fcf-yield <GO> |
| Operating Margin ACTIVE | -60.00% | -33.70% | -26.30 | QDEL | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -41.50% | -18.50 | QDEL | /net-margins <GO> |
| Revenue Growth (YoY) | 16.90% | -1.90% | +18.80 | NTLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.17 | 0.20 | +0.97 | NTLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 56.7 | -10.70 | QDEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.63B | $962.1M | $671.8M | NTLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NTLA REV | QDEL REV | NTLA GROSS % | QDEL GROSS % | NTLA FCF | QDEL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $67.7M | $2.73B | — | — | -$395.9M | -$83.0M |
| FY 2024 | $57.9M | $2.78B | — | — | -$354.7M | -$112.1M |
| FY 2023 | $36.3M | $3.00B | — | — | -$394.1M | $280.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NTLA // BETA —
QDEL // BETA —